GLP-1 TV · News & media · 13 videos
Good Morning America
@GMA on YouTube ↗Good Morning America is a YouTube channel of news and media coverage of GLP-1 medications, with 5.5M subscribers and a verified badge. GLP-1 TV holds 13 of its videos, 7M views between them, the newest from May 2026.
- Medications covered
- Ozempic (4), Wegovy (2), Zepbound (1), Retatrutide (1)
- Topics that come up most
- Side effects, Cost and insurance, The trials, Stopping and maintenance, Dose change, Weigh-in and results
2:40This is what happens when you stop taking OzempicGood Morning AmericaDetails5 key moments
This Good Morning America segment asks what happens when a person stops taking Ozempic.
- 0:00 Introduction to Ozempic
- 0:07 What are GLP-1 agonists?
- 0:33 Uses and administration
- 1:03 Side effects and risks
- 1:32 Effects of stopping treatment
- Who is speaking: News or media
4:41What happens to your body when you stop taking weight-loss drugs l GMAGood Morning AmericaDetails
This Good Morning America segment, part of a series on weight loss medications, looks at what happens when people stop taking drugs such as Ozempic and Wegovy.
- Side effects mentioned: muscle loss
- Who is speaking: News or media
1:45Does Wegovy help to lose weight?Good Morning AmericaDetails
In this short Good Morning America segment, a doctor identified as Dr. Ashton answers the question of how Wegovy helps with weight loss. She says Wegovy is the brand name of a prescription medication called semaglutide.
- Who is speaking: News or media
4:04Eil Lilly announces Zepbound to be sold directly to consumersGood Morning AmericaDetails4 key moments
In this Good Morning America segment, a reporter interviews Eli Lilly CEO Dave Ricks about a new way to buy Zepbound. According to the video, Lilly is offering Zepbound in vial form through its direct-to-consumer platform, Lilly Direct.
- Doses mentioned: 5 mg
- Who is speaking: News or media
2:55New data released on weight loss drug retatrutideGood Morning AmericaDetails3 key moments
This Good Morning America segment features the show's chief medical correspondent, who discusses retatrutide, an experimental weight loss medication still in clinical trials.
- Doses mentioned: 4 mg
- Who is speaking: News or media
2:15Hims & Hers' Super Bowl ad sparks backlashGood Morning AmericaDetails
According to the video, a Good Morning America segment reports on controversy around a Super Bowl ad from the telehealth company Hims & Hers.
- Who is speaking: News or media
4:24Exploring side effects of popular weight-loss drugs | GMAGood Morning AmericaDetails
A news or media piece talks through a GLP-1 side effects. It has no captions we could read, so this is drawn from its title and description.
- Who is speaking: News or media
3:03I’m worried I’ll gain weight when I get off Ozempic. Any tips?Good Morning AmericaDetails3 key moments
In this Good Morning America segment, a viewer asks what to do about weight coming back while easing off Ozempic. The doctor, identified as Dr Jen, says the answer depends on the individual, but people should expect that some of the weight lost on GLP-1 agonists will return.
- Who is speaking: News or media
2:20Diabetes drug Mounjaro shows heart benefits: StudyGood Morning AmericaDetails3 key moments
In this Good Morning America segment, ABC News medical correspondent Dr. Darien Sutton discusses a new study of Mounjaro, a diabetes drug.
- Who is speaking: News or media
3:36Popular weight loss drug Wegovy drops cash price 30%, manufacturer saysGood Morning AmericaDetails
This Good Morning America segment reports that Novo Nordisk is lowering the self-pay price of Wegovy, according to the video.
- Prices mentioned: $500 a month, $349 a month and $149 a month
- Who is speaking: News or media
3:36FDA approves new weight-loss pill, FoundayoGood Morning AmericaDetails4 key moments
In this Good Morning America segment, chief medical correspondent Dr. Tara Narula discusses a new once-a-day weight-loss pill from Eli Lilly called Foundayo, which the FDA has approved.
- Prices mentioned: $149 a month, $25 a month and $50 a month
- Who is speaking: News or media
3:22New study shows GLP-1 weight loss drugs can significantly reduce alcohol intakeGood Morning AmericaDetails3 key moments
This Good Morning America segment features neurologist Dr. Leah Croll discussing a new study on whether GLP-1 weight loss drugs could help people who drink heavily.
- Who is speaking: News or media
3:11The effect of Ozempic use on mental healthGood Morning AmericaDetails
This Good Morning America segment reports on psychiatrists who are prescribing Ozempic-type drugs to patients on mental health medications.
- Who is speaking: News or media
Where semaglutide costs least today
The three cheapest partner programs for semaglutide, all in per month, checked weekly. Brand Ozempic and compounded versions are different products; each row says which it is.
What each Good Morning America video covers
The opening line of our summary for each video, most-watched first.
- This is what happens when you stop taking Ozempic
This Good Morning America segment asks what happens when a person stops taking Ozempic.
6.1M views · Feb 2023 - What happens to your body when you stop taking weight-loss drugs l GMA
This Good Morning America segment, part of a series on weight loss medications, looks at what happens when people stop taking drugs such as Ozempic and Wegovy.
448K views · May 2023 - Does Wegovy help to lose weight?
In this short Good Morning America segment, a doctor identified as Dr. Ashton answers the question of how Wegovy helps with weight loss.
126K views · Apr 2022 - Eil Lilly announces Zepbound to be sold directly to consumers
In this Good Morning America segment, a reporter interviews Eli Lilly CEO Dave Ricks about a new way to buy Zepbound.
88.7K views · Aug 2024 - New data released on weight loss drug retatrutide
This Good Morning America segment features the show's chief medical correspondent, who discusses retatrutide, an experimental weight loss medication still in clinical trials.
75.9K views · May 2026 - Hims & Hers' Super Bowl ad sparks backlash
According to the video, a Good Morning America segment reports on controversy around a Super Bowl ad from the telehealth company Hims & Hers.
46K views · Feb 2025 - I’m worried I’ll gain weight when I get off Ozempic. Any tips?
In this Good Morning America segment, a viewer asks what to do about weight coming back while easing off Ozempic.
17.7K views · Dec 2023 - Diabetes drug Mounjaro shows heart benefits: Study
In this Good Morning America segment, ABC News medical correspondent Dr. Darien Sutton discusses a new study of Mounjaro, a diabetes drug.
14.2K views · Aug 2025 - Popular weight loss drug Wegovy drops cash price 30%, manufacturer says
This Good Morning America segment reports that Novo Nordisk is lowering the self-pay price of Wegovy, according to the video.
8.9K views · Nov 2025 - FDA approves new weight-loss pill, Foundayo
In this Good Morning America segment, chief medical correspondent Dr. Tara Narula discusses a new once-a-day weight-loss pill from Eli Lilly called Foundayo, which the FDA has approved.
5.7K views · Apr 2026 - New study shows GLP-1 weight loss drugs can significantly reduce alcohol intake
This Good Morning America segment features neurologist Dr. Leah Croll discussing a new study on whether GLP-1 weight loss drugs could help people who drink heavily.
4.7K views · May 2025 - The effect of Ozempic use on mental health
This Good Morning America segment reports on psychiatrists who are prescribing Ozempic-type drugs to patients on mental health medications.
4.4K views · Nov 2023
Watched them? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.






